Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
-66.67%
0%
-66.67%
1 Year
-98.67%
0%
-98.67%
2 Years
-99.99%
0%
-99.99%
3 Years
-99.96%
0%
-99.96%
4 Years
-100.0%
0%
-100.0%
5 Years
-100.0%
0%
-100.0%
BIMI International Medical, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
16.91%
EBIT Growth (5y)
-210.31%
EBIT to Interest (avg)
-6.66
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.12
Sales to Capital Employed (avg)
1.16
Tax Ratio
0.01%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.52%
ROCE (avg)
0
ROE (avg)
3.59%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
0.00
EV to EBIT
-0.24
EV to EBITDA
-0.25
EV to Capital Employed
0.11
EV to Sales
0.06
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-44.80%
ROE (Latest)
-75.05%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 1 Schemes (0.06%)
Foreign Institutions
Held by 1 Foreign Institutions (0.06%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'23 - YoY
Sep'23
Sep'22
Change(%)
Net Sales
2.50
7.30
-65.75%
Operating Profit (PBDIT) excl Other Income
-3.10
-3.10
Interest
0.00
0.20
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-3.10
-3.70
16.22%
Operating Profit Margin (Excl OI)
-1,248.30%
-422.70%
-82.56%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2023 is -65.75% vs -47.10% in Sep 2022
Consolidated Net Profit
YoY Growth in quarter ended Sep 2023 is 16.22% vs -117.65% in Sep 2022
Annual Results Snapshot (Consolidated) - Dec'22
Dec'22
Dec'21
Change(%)
Net Sales
11.80
27.10
-56.46%
Operating Profit (PBDIT) excl Other Income
-9.70
-7.90
-22.78%
Interest
3.40
0.40
750.00%
Exceptional Items
-5.40
-26.10
79.31%
Consolidate Net Profit
-21.60
-34.90
38.11%
Operating Profit Margin (Excl OI)
-841.30%
-299.40%
-54.19%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2022 is -56.46% vs 111.72% in Dec 2021
Consolidated Net Profit
YoY Growth in year ended Dec 2022 is 38.11% vs -818.42% in Dec 2021
About BIMI International Medical, Inc. 
BIMI International Medical, Inc.
Retailing
BOQI INTERNATIONAL MEDICAL INC is a company engaged in pharmacy business. The Company has directly owned stores under the brand Boqi Pharmacy in China, and it sells medicines and other health-related products through the stores. The products sold are mainly comprised of prescription drugs, over-the-counter (OTC) drugs, nutritional supplements, sundry products and medical devices.
Company Coordinates 
Company Details
3105 Tower C, 390 Qingnian Avenue, Heping District SHENYANG LIA : 116000
Registrar Details






